{
    "Trade/Device Name(s)": [
        "First Sign Drug of Abuse Buprenorphine Cup Test",
        "First Sign Drug of Abuse Buprenorphine Dip Card Test",
        "First Sign Drug of Abuse Butalbital Cup Test",
        "First Sign Drug of Abuse Butalbital Dip Card Test",
        "First Sign Drug of Abuse Morphine Cup Test",
        "First Sign Drug of Abuse Morphine Dip Card Test"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K152551",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809",
        "K041712"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DIS"
    ],
    "Summary Letter Date": "September 1, 2015",
    "Summary Letter Received Date": "September 8, 2015",
    "Submission Date": "November 6, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3150"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Barbiturate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Butalbital",
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Drug of Abuse Cup and Dip Card Tests for qualitative detection of Buprenorphine, Butalbital, and Morphine in urine",
    "Indications for Use Summary": "Qualitative determination of Buprenorphine, Butalbital, or Morphine in human urine at established cut-off concentrations, providing preliminary test results for in vitro diagnostic use; intended for over-the-counter and prescription use",
    "fda_folder": "Toxicology"
}